Abstract
OPIATE antagonists differ from opiates only by the replacement of the N-methyl substituent with an N-allyl, N-cylcopropylmethyl or related group. Antagonists can reverse the pharmacological effects of opiates and so are important in the treatment of opiate overdose. Drugs that combine agonist and antagonist activities have potential as relatively nonaddicting analgesics. Although their mutual pharmacological antagonism indicates that they act at the same binding site, pharmacological discrepancies have prompted speculation that agonist and antagonist binding sites are separate1,2. Biochemical study of receptor binding3–16 has shown that although opiate agonists and antagonists compete for the same receptor3,4, there are differences in the way they interact with them7,10. Physiological concentrations of sodium enhance the binding of 3H-antagonists but reduce that of 3H-agonists. Sodium diminishes the ability of pure agonists to inhibit binding of 3H-naloxone to the receptor, but has little influence on inhibitory effects of pure antagonists and intermediate effects on those of combination agonist–antagonist drugs. The molecular basis for these differences, however, is unclear. As a first step in this direction we now report that binding of opiate receptors is much more sensitive to degradation by protein reagents which are known to modify sulphydryl groups than is binding by opiate antagonists. This suggests that distinct binding sites exist for agonists and antagonists, although they may both be on the same receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Martin, W. R., Pharmac. Rev., 19, 463–521 (1967).
Martin, W. R., Gorodetzky, C. W., and Thompson, W. O., Agonist and antagonist actions of narcotic analgesic drugs (edit. by Kosterlitz, H. W., Collier, H. O., and Villareal, J. E.), 30–40 (University Park Press, Baltimore, 1973).
Pert, C. B., and Snyder, S. H., Science, 179, 1011–1014 (1973).
Pert, C. B., and Snyder, S. H., Proc. natn. Acad. Sci. U.S.A., 70, 2243–2247 (1973).
Pasternak, G. W., and Snyder, S. H., Molec. Pharmac., 10, 183–193 (1974).
Pasternak, G. W., and Snyder, S. H., Nature (in the press).
Pert, C. B., Pasternak, G. W., and Snyder, S. H., Science, 182, 1359–1361 (1973).
Kuhar, M. J., Pert, C. B., and Snyder, S. H., Nature, 245, 447–450 (1973).
Pert, C. B., Snowman, A., and Snyder, S. H., Brain Res., 70, 184–188 (1974).
Pert, C. B., and Snyder, S. H., Molec. Pharmacol., 10, 868–879 (1974).
Terenius, L., Acta Pharmac. Toxicol., 33, 377–384 (1973).
Terenius, L., Acta Pharmac. Toxicol., 34, 88–91 (1974).
Simon, E. J., Hiller, J. M., and Edelman, I., Proc. natn. Acad. Sci. U.S.A., 70, 1947–1949 (1973).
Wong, D. T., and Horng, J. S., Life Sci., 13, 1543–1556 (1973).
Klee, W. A., and Streaty, R. A., Nature, 248, 61–63 (1974).
Hitzemann, R. J., and Loh, H. H., Third Ann. Soc. Neuroscience Mtg, Abstr., 350 (1973).
Crestfield, A. M., Stein, W. H., and Moore, S., J. biol. Chem., 238, 2421–2428 (1963).
Smyth, D. G., Nagamatsu, A., and Fruton, J. S., J. Am. chem. Soc., 82, 4600–4604 (1960).
Riggs, A., J. biol. Chem., 236, 1948–1954 (1961).
Crestfield, A. M., Stein, W. H., and Moore, S., J. biol. Chem., 238, 2413–2420 (1963).
Cohen, L. A., The Enzymes (edit. by Boyer, P.), 1, 148–211 (Academic, New York, 1970).
Vallee, B. L., and Riordan, J. F., Ann. Rev. Biochem., 38, 733–794 (1969).
Cohen, L. A., Ann. Rev. Biochem., 37, 695–726 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
WILSON, H., PASTERNAK, G. & SNYDER, S. Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents. Nature 253, 448–450 (1975). https://doi.org/10.1038/253448a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/253448a0
This article is cited by
-
Conformational malleability of opiate receptors: Sulfhydryl modification alters ion-induced�/?-ligand selectivity shifts in rat striatal sections
Cellular and Molecular Neurobiology (1982)
-
Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cells
Nature (1979)
-
Opiate receptor in normal and drug altered brain function*
Nature (1975)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.